Hexokinase 2, a key enzyme in the glycolytic pathway, is also significantly overexpressed in both retinoblastoma and uveal melanoma, facilitating the shift to aerobic glycolysis, a hallmark of cancer cell metabolism (Tang et al., 2021; Liu et al., 2018). Here, HK2 is linked to retinoblastoma.